Xinzhi Medical completed a strategic financing of RMB 8.66 million

Xinzhi Medical is a research and development company of cardiovascular interventional therapy, dedicated to promoting the technological innovation of cardiovascular interventional therapy. And drug coating technology as a platform, to become a domestic provider of interventional non-implantation solutions. Recently completed a strategic financing of 8.66 million yuan, and the investor is Baixinan. The post-investment valuation is 100 million yuan, accounting for 8.66%.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.